Oncology

Ifinatamab deruxtecan (I-DXd)

Daiichi Sankyo / MSD

B7-H3-directed ADC with strong SCLC signal. IDeate-Lung Phase 3 trials ongoing.

Small Cell Lung Cancer

Linked Studies

Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants

Loading comments…

Also Known As

Other names

ifinatamab